eNPS at Novartis Institutes for Biomedical Research
Novartis Institutes for Biomedical Research's Employee Net Promoter Score (eNPS) is 20, as rated by 10 employees. Employee Net Promoter Score tracks Novartis Institutes for Biomedical Research employees' answers to this question: On a scale from 0-10, how likely are you to recommend working at Novartis Institutes for Biomedical Research to a friend? Today, 40% of Novartis Institutes for Biomedical Research employees would encourage their friends to become coworkers, whereas 40% are neutral and 20% would not recommend working at Novartis Institutes for Biomedical Research to their friends.
Where This Score Ranks Novartis Institutes for Biomedical Research's eNPS
- TOP25%
In the Top 25% of 1666 Similar Sized Companies on Comparably
- 2nd
2nd place versus 2 competitors rated on Comparably
- Promoters
- Passives
- Detractors
Novartis Institutes for Biomedical Research eNPS At a Glance
Novartis Institutes for Biomedical Research employees are more likely to recommend Novartis Institutes for Biomedical Research as a great place to work. The employee Net Promoter Score is a simple way to measure loyalty and an employee's willingness to recommend working at their company to friends.
Male employees and Caucasian employees provided the highest scores when answering the question, “On a scale from 0-10, how likely are you to recommend working at Novartis Institutes for Biomedical Research to a friend?” Based on 10 ratings, Novartis Institutes for Biomedical Research ranks 2nd place versus its 2 competitors and is right below Takeda.
The last rating was provided months ago.
Novartis Institutes for Biomedical Research's eNPS Trendline
- Novartis Institutes for Biomedical Research20
- Similar Size on Comparably
Novartis Institutes for Biomedical Research's eNPS Rank Against Similar Sized Companies on Comparably
Novartis Institutes for Biomedical Research ranks in the Top 25% of other companies on Comparably with 5,001-10,000 Employees for eNPS Score.
Questions Recently Asked asked Novartis Institutes for Biomedical Research